Novelix Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	29.59	6.79	1.18	2.75	28.9
Short-Term Investments	-	-	25	25	-
Trading Asset Securities	-	-	8.73	3.91	1.19
Cash & Short-Term Investments	29.59	6.79	34.91	31.66	30.09
Cash Growth	335.97%	-80.56%	10.26%	5.22%	29.25%
Accounts Receivable	589.62	181.37	0.13	1.9	12.32
Other Receivables	-	1.58	2.83	3.66	3.89
Receivables	687.92	253.18	2.97	6.34	20.38
Inventory	144.32	8.43	3.21	4.29	8.77
Prepaid Expenses	-	0.18	0.01	0.13	0.08
Other Current Assets	27.28	0.75	0.2	-	-0
Total Current Assets	889.11	269.33	41.3	42.43	59.31
Property, Plant & Equipment	15.22	1.86	1.18	1.74	4.55
Long-Term Investments	0.43	0.43	30.64	27.75	4.22
Other Intangible Assets	19.2	0	0	0	0.11
Long-Term Deferred Tax Assets	0.27	0.45	0.54	0.65	0.66
Other Long-Term Assets	-	0	-	-	18.54
Total Assets	924.23	272.06	73.65	72.57	87.38
Accounts Payable	402.54	93.01	0.03	0.54	8.83
Accrued Expenses	-	3.36	0.07	0.07	0.09
Current Portion of Long-Term Debt	-	-	-	-	0.34
Current Income Taxes Payable	-	0.3	-	-	-
Other Current Liabilities	13.59	-	0	0.01	0.05
Total Current Liabilities	416.13	96.67	0.1	0.62	9.29
Long-Term Debt	43.22	-	-	-	1.31
Total Liabilities	459.35	96.67	0.1	0.62	10.6
Common Stock	210.85	99.5	81	81	81
Additional Paid-In Capital	-	94.65	12.15	12.15	12.15
Retained Earnings	-	-18.76	-19.6	-24.32	-22.74
Comprehensive Income & Other	254.03	-	-	3.12	3.63
Total Common Equity	464.88	175.39	73.55	71.95	74.04
Minority Interest	-	-	-	-	2.74
Shareholders' Equity	464.88	175.39	73.55	71.95	76.78
Total Liabilities & Equity	924.23	272.06	73.65	72.57	87.38
Total Debt	43.22	-	-	-	1.65
Net Cash (Debt)	-13.63	6.79	34.91	31.66	28.44
Net Cash Growth	-	-80.56%	10.26%	11.31%	22.18%
Net Cash Per Share	-0.65	0.72	3.35	3.91	3.51
Filing Date Shares Outstanding	21.21	9.95	8.1	8.1	8.1
Total Common Shares Outstanding	21.21	9.95	8.1	8.1	8.1
Working Capital	472.98	172.66	41.2	41.81	50.02
Book Value Per Share	21.92	17.63	9.08	8.88	9.14
Tangible Book Value	445.68	175.39	73.55	71.95	73.93
Tangible Book Value Per Share	21.02	17.63	9.08	8.88	9.13
Buildings	-	-	1.43	1.43	1.43
Machinery	-	-	11.85	12.04	14.54